Please ensure Javascript is enabled for purposes of website accessibility
Home / Products / Recombinant Protein / Other Proteins

Recombinant Nipah virus/NiV M/Matrix Protein, N-His

Catalog #:   YVV18501 Specific References (30) DATASHEET
Applications: ELISA, Immunogen, SDS-PAGE, WB, Bioactivity testing in progress
Expression system: E. coli
Accession: Q9IK90
Protein length: Met1-Gly352
Overview

Catalog No.

YVV18501

Expression system

E. coli

Species

Nipah virus

Protein length

Met1-Gly352

Predicted molecular weight

42.09 kDa

Nature

Recombinant

Endotoxin level

Please contact with the lab for this information.

Purity

>90% as determined by SDS-PAGE.

Accession

Q9IK90

Applications

ELISA, Immunogen, SDS-PAGE, WB, Bioactivity testing in progress

Form

Lyophilized

Storage buffer

Lyophilized from a solution in PBS pH 7.4, 0.02% NLS, 1mM EDTA, 4% Trehalose, 1% Mannitol.

Reconstitution

Reconstitute in sterile water for a stock solution.

Shipping

In general, proteins are provided as lyophilized powder/frozen liquid. They are shipped out with dry ice/blue ice unless customers require otherwise.

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt.

Alternative Names

Matrix protein, Protein M, M protein

Data Image
  • SDS-PAGE
    SDS PAGE for recombinant Nipah virus/NiV M/Matrix Protein
References

The E3 ligase RAD18-mediated ubiquitination of henipavirus matrix protein promotes its nuclear-cytoplasmic trafficking and viral egress., PMID:39628457

High-throughput virtual screening of Streptomyces spp. metabolites as antiviral inhibitors against the Nipah virus matrix protein., PMID:38968780

Henipaviruses and lyssaviruses target nucleolar treacle protein and regulate ribosomal RNA synthesis., PMID:36479968

Measles and Nipah virus assembly: Specific lipid binding drives matrix polymerization., PMID:35857835

Paramyxovirus-Like Particles as Protein Delivery Vehicles., PMID:34379508

A Novel Strategy for the Development of Vaccines for SARS-CoV-2 (COVID-19) and Other Viruses Using AI and Viral Shell Disorder., PMID:33006287

Replication of a Nipah Virus Encoding a Nuclear-Retained Matrix Protein., PMID:31665345

Nipah Virus-Like Particle Egress Is Modulated by Cytoskeletal and Vesicular Trafficking Pathways: a Validated Particle Proteomics Analysis., PMID:31551400

Nipah virus induces two inclusion body populations: Identification of novel inclusions at the plasma membrane., PMID:31034506

In silico identification and characterization of common epitope-based peptide vaccine for Nipah and Hendra viruses., PMID:28756915

Nuclear localization and secretion competence are conserved among henipavirus matrix proteins., PMID:28056216

The Matrix Protein of Nipah Virus Targets the E3-Ubiquitin Ligase TRIM6 to Inhibit the IKKε Kinase-Mediated Type-I IFN Antiviral Response., PMID:27622505

Eukaryotic elongation factor 1-beta interacts with the 5' untranslated region of the M gene of Nipah virus to promote mRNA translation., PMID:27236461

Production of the virus-like particles of nipah virus matrix protein in Pichia pastoris as diagnostic reagents., PMID:27088434

Morbillivirus and henipavirus attachment protein cytoplasmic domains differently affect protein expression, fusion support and particle assembly., PMID:26813519

C-Terminal DxD-Containing Sequences within Paramyxovirus Nucleocapsid Proteins Determine Matrix Protein Compatibility and Can Direct Foreign Proteins into Budding Particles., PMID:26792745

Nipah Virus Matrix Protein Influences Fusogenicity and Is Essential for Particle Infectivity and Stability., PMID:26676785

Expression and purification of the matrix protein of Nipah virus in baculovirus insect cell system., PMID:26519022

Evidence for ubiquitin-regulated nuclear and subnuclear trafficking among Paramyxovirinae matrix proteins., PMID:25782006

Matrix proteins of Nipah and Hendra viruses interact with beta subunits of AP-3 complexes., PMID:25210190

Virus particle release from glycosphingolipid-enriched microdomains is essential for dendritic cell-mediated capture and transfer of HIV-1 and henipavirus., PMID:24872578

ANP32B is a nuclear target of henipavirus M proteins., PMID:24823948

Nipah virus entry and egress from polarized epithelial cells., PMID:23283941

Ubiquitin-regulated nuclear-cytoplasmic trafficking of the Nipah virus matrix protein is important for viral budding., PMID:21085610

PIV5 M protein interaction with host protein angiomotin-like 1., PMID:19932912

Production of the matrix protein of Nipah virus in Escherichia coli: virus-like particles and possible application for diagnosis., PMID:19666056

The YPLGVG sequence of the Nipah virus matrix protein is required for budding., PMID:19000317

Mutation of YMYL in the Nipah virus matrix protein abrogates budding and alters subcellular localization., PMID:17005661

Production and characterization of monoclonal antibodies against binary ethylenimine inactivated Nipah virus., PMID:16226320

In silico identification of a putative new paramyxovirus related to the Henipavirus genus., PMID:15527844

Datasheet
$ 313
Product specifications
100 μg 313 1 mg 1629

Contact Information

Order: order@antibodysystem.com

Mail: support@antibodysystem.com

Distributor list

For research use only. Not for human or drug use.

Need help with your order?

Find out more about placing an order here

Recombinant Nipah virus/NiV M/Matrix Protein, N-His [YVV18501]
Terms of sale Website terms of use Cookie policy Privacy
Copyright © 2025 AntibodySystem SAS. All Rights Reserved.            All Products are for Research Use Only